InvestSMART

Invion Limited (ASX: IVX) - Announcements

- Current share price for IVX : $0.039

ASX company news and announcements for Invion Limited (IVX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Invion Limited (IVX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Invion Limited (IVX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Invion Limited (IVX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$4 Update on 3M collaboration for inhaled INV102 (nadolol) 24 Sep 2014 11:14AM $0.079 $0.039 fallen by 50.63%
$4 Phase 2 asthma trial interim blinded data 23 Sep 2014 9:41AM $0.079 $0.039 fallen by 50.63%
$4 Lupus clinical trial update 8 Sep 2014 9:55AM $0.069 $0.039 fallen by 43.48%
$4 Appendix 4E and Full Year Statutory Accounts 28 Aug 2014 3:41PM $0.083 $0.039 fallen by 53.01%
$4 Appendix 4C - quarterly 31 Jul 2014 1:21PM $0.070 $0.039 fallen by 44.29%
$4 Litigation update - orders on interest and costs 23 Jun 2014 8:58AM $0.074 $0.039 fallen by 47.30%
$4 Litigation update - Receipt of judgment 4 Jun 2014 12:17PM $0.064 $0.039 fallen by 39.06%
$4 Appendix 4C - quarterly 28 Apr 2014 10:03AM $0.068 $0.039 fallen by 42.65%
$4 Litigation update 14 Mar 2014 5:01PM $0.078 $0.039 fallen by 50%
$4 Rights Issue Information Booklet 26 Feb 2014 9:09AM $0.077 $0.039 fallen by 49.35%
$4 Invion announces Rights Issue Entitlement Offer 26 Feb 2014 9:09AM $0.077 $0.039 fallen by 49.35%
$4 Appendix 4D and Half Yearly Accounts 25 Feb 2014 1:05PM $0.089 $0.039 fallen by 56.18%
$4 Invion completes Placement and announces Rights Issue 21 Feb 2014 9:23AM $0.089 $0.039 fallen by 56.18%
$4 Trading Halt 19 Feb 2014 9:16AM $0.094 $0.039 fallen by 58.51%
$4 Appendix 4C - quarterly 31 Jan 2014 1:40PM $0.105 $0.039 fallen by 62.86%
$4 FDA lifts hold on smoking cessation trial 29 Jan 2014 9:40AM $0.093 $0.039 fallen by 58.06%
$4 Smoking cessation study hold 20 Dec 2013 11:58AM $0.085 $0.039 fallen by 54.12%
$4 Appendix 4C - quarterly 31 Oct 2013 9:42AM $0.120 $0.039 fallen by 67.50%
$4 Invion announces in-licence agreement 28 Oct 2013 9:14AM $0.105 $0.039 fallen by 62.86%
$4 Response to ASX Price Query 22 Oct 2013 2:33PM $0.105 $0.039 fallen by 62.86%
$4 App 4E / Full Year Statutory Accounts 23 Aug 2013 3:27PM $0.068 $0.039 fallen by 42.65%
$4 Invion to receive up to 1.4M tax rebate 1 Aug 2013 10:55AM $0.053 $0.039 fallen by 26.42%
$4 Appendix 4C - quarterly 31 Jul 2013 12:57PM $0.055 $0.039 fallen by 29.09%
$4 Commencement of chronic bronchitis clinical trial 22 Jul 2013 9:18AM $0.035 $0.039 risen by 11.43%
$4 Commencement of phase II lupus trial 18 Jul 2013 11:03AM $0.035 $0.039 risen by 11.43%

676 - 700 of 717 results

Page 28 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.